Cerus (CERS)
(Delayed Data from NSDQ)
$1.84 USD
-0.01 (-0.54%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.83 -0.01 (-0.54%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Brokerage Reports
Cerus Corporation [CERS]
Reports for Purchase
Showing records 61 - 69 ( 69 total )
Company: Cerus Corporation
Industry: Medical - Products
Company: Cerus Corporation
Industry: Medical - Products
LIFE SCIENCES: 2012 Life Sciences and Healthcare Preview: Macro and Sector Trends; Catalysts; Top Picks
Provider: WEDBUSH SECURITIES INC.
Analyst: JAMES S
Company: Cerus Corporation
Industry: Medical - Products
Reaffirming OUTPERFORM On Great 3Q11 Results, Upped Guidance & Lower Clinical Trial Hurdles
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
Company: Cerus Corporation
Industry: Medical - Products
Reiterating OUTPERFORM Following Meetings with Management
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
French Blood Establishment Finally Issues Tender for INTERCEPT Representing a Positive - Size & Scope of Contract Yet Unknown
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
Reaffirming OUTPERFORM Rating on Solid 2Q11 Sales
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Cerus Corporation
Industry: Medical - Products
Update: Theorizing on Recent Insider Purchases; At-the-Market Deal Announcement Drove Selloff
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z